3,4-Dimethoxybenzamide
CAS No. 1521-41-1
3,4-Dimethoxybenzamide ( —— )
Catalog No. M28208 CAS No. 1521-41-1
3,4-Dimethoxybenzamide, amide, is isolated from the solid culture of Streptoverticillium morookaense. 3,4-Dimethoxybenzamide can be used as the starting material to preparation Itopride hydrochloride.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 45 | In Stock |
|
100MG | 68 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3,4-Dimethoxybenzamide
-
NoteResearch use only, not for human use.
-
Brief Description3,4-Dimethoxybenzamide, amide, is isolated from the solid culture of Streptoverticillium morookaense. 3,4-Dimethoxybenzamide can be used as the starting material to preparation Itopride hydrochloride.
-
Description3,4-Dimethoxybenzamide, amide, is isolated from the solid culture of Streptoverticillium morookaense . 3,4-Dimethoxybenzamide can be used as the starting material to preparation Itopride hydrochloride.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorurotensin-II (UT)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1521-41-1
-
Formula Weight181.2
-
Molecular FormulaC9H11NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(cc1OC)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cosenzi A. Non peptidic urotensin II antagonists: perspectives for a new class of drugs. Cardiovasc Hematol Agents Med Chem. 2008 Apr;6(2):80-91.
molnova catalog
related products
-
VPC-18005
VPC-18005 is a luciferase inhibitor. VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain thereby disrupting the ERG binding to DNA.
-
Soyasaponin Ba
Soyasaponin Ba may represent viable candidates for effective vaccine adjuvants due to their higher and lower or non-haemolytic effects.
-
Apraglutide TFA (129...
Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.